期刊论文详细信息
BMC Complementary Medicine and Therapies
In vitro inhibitory effect of obtusofolin on the activity of CYP3A4, 2C9, and 2E1
Shasha Han1  Na Liu1  Ping Chen1  Junxia Sun1  Xiaojun Du2 
[1] Department of Ophthalmology, Dongying People’s Hospital, No. 317, Nanyi Road, Dongcheng, 257091, Dongying, Shandong Province, China;Department of Ophthalmology, Shengli Oilfield Central Hospital, 257034, Dongying, Shandong, China;
关键词: Obtusofolin;    Cytochrome P450 enzymes;    Dose-dependent;    Time-dependent;    Drug-drug interaction;   
DOI  :  10.1186/s12906-021-03397-w
来源: Springer
PDF
【 摘 要 】

BackgroundObtusofolin is the major active ingredient of Catsia tora L., which possesses the activity of improving eyesight and protecting the optic nerve. Investigation on the interaction of obtusofolin with cytochrome P450 enzymes (CYP450s) could provide a reference for the clinical application of obtusofolin.MethodsThe effect of obtusofolin on the activity of CYP450s was investigated in the presence of 100 μM obtusofolin in pooled human liver microsomes (HLMs) and fitted with the Lineweaver–Burk plots to characterize the specific inhibition model and kinetic parameters.ResultsObtusofolin was found to significantly inhibited the activity of CYP3A4, 2C9, and 2E1. In the presence of 0, 2.5, 5, 10, 25, 50, and 100 μM obtusofolin, the inhibition of these CYP450s showed a dose-dependent manner with the IC50 values of 17.1 ± 0.25, 10.8 ± 0.13, and 15.5 ± 0.16 μM, respectively. The inhibition of CYP3A4 was best fitted with the non-competitive inhibition model with the Ki value of 8.82 μM. While the inhibition of CYP2C9 and 2E1 was competitive with the Ki values of 5.54 and 7.79 μM, respectively. After incubating for 0, 5, 10, 15, and 30 min, the inhibition of CYP3A4 was revealed to be time-dependent with the KI value of 4.87 μM− 1 and the Kinact value of 0.0515 min− 1.ConclusionsThe in vitro inhibitory effect of obtusofolin implying the potential drug-drug interaction between obtusofolin and corresponding substrates, which needs further in vivo validations.

【 授权许可】

CC BY   

【 预 览 】
附件列表
Files Size Format View
RO202110141351529ZK.pdf 938KB PDF download
  文献评价指标  
  下载次数:14次 浏览次数:6次